Skip to content
Subscriber Only

Recursion Pharmaceuticals Expands IPO to Raise $436 Million

Recursion Pharmaceuticals Inc., which uses machine learning to hunt for new therapies, raised $436 million in an upsized initial public offering priced at the top of a marketed range.

The Salt Lake City-based company sold about 24 million shares on Thursday for $18 each, according to data compiled by Bloomberg. The company, which marketed the shares for $16 to $18, twice earlier Thursday increased the number of shares to be sold.